SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-341048
Filing Date
2012-08-07
Accepted
2012-08-07 16:37:19
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d353574d10q.htm 10-Q 492288
2 RATIO OF EARNINGS TO FIXED CHARGES d353574dex121.htm EX-12.1 39344
3 SECTION 302 CEO CERTIFICATION d353574dex311.htm EX-31.1 9617
4 SECTION 302 CFO CERTIFICATION d353574dex312.htm EX-31.2 9617
5 SECTION 906 CEO CERTIFICATION d353574dex321.htm EX-32.1 3809
6 SECTION 906 CFO CERTIFICATION d353574dex322.htm EX-32.2 3809
  Complete submission text file 0001193125-12-341048.txt   3164311

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT omer-20120630.xml EX-101.INS 348910
8 XBRL TAXONOMY EXTENSION SCHEMA omer-20120630.xsd EX-101.SCH 34837
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omer-20120630_cal.xml EX-101.CAL 39943
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20120630_def.xml EX-101.DEF 184065
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20120630_lab.xml EX-101.LAB 279489
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20120630_pre.xml EX-101.PRE 215761
Mailing Address 1420 5TH AVE SUITE 2600 SEATTLE WA 98101
Business Address 1420 5TH AVE SUITE 2600 SEATTLE WA 98101 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 121013902
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences